Identification of the precise mechanisms, by which activation of TGF-β signaling, observed in low responders, impacts insulin sensitivity, provides ground for the development of novel strategies to improve glycemic control in patients with risk for T2D. Here, TGFB1 is linked to type 2 diabetes mellitus.